Related Experiment Videos
The restriction point of the cell cycle
Mikhail V Blagosklonny1, Arthur B Pardee
1National Cancer Institute; National Institutes of Health; Bethesda, Maryland 20892 USA. mikhailb@mal.nih.gov
Cell Cycle (Georgetown, Tex.)
|November 14, 2002
Summary
The cell cycle restriction point, discovered in 1974, is complex and linked to DNA damage checkpoints. Its loss in cancer disrupts control, causing resistance to antimitogens and some cancer therapies.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The restriction point (R-point) concept in cell cycle regulation was established in 1974 based on cell biology.
- The R-point's molecular basis and its key regulatory factor have been subjects of ongoing research.
Purpose of the Study:
- To explore the complex nature of the restriction point and its molecular underpinnings.
- To investigate the relationship between the restriction point and DNA damage checkpoints.
- To understand the implications of R-point loss in cancer, particularly regarding checkpoint control and therapeutic resistance.
Main Methods:
- Review and synthesis of existing cell biological and molecular data.
- Analysis of the role of cyclin D in relation to the R-factor criteria.
- Discussion of the interplay between the restriction knot, DNA damage checkpoints, and cancer.
Main Results:
- Cyclin D aligns with the criteria for the restriction point factor, but the R-point's regulation is more intricate.
- A significant relationship exists between the restriction knot and DNA damage-checkpoints.
- Loss of the restriction point in cancer cells leads to compromised checkpoint control.
Conclusions:
- The restriction point is a critical regulatory node in the cell cycle with complex molecular interactions.
- Dysregulation of the restriction point in cancer contributes to uncontrolled cell proliferation and evasion of cell death.
- Understanding the R-point's role is crucial for developing effective anticancer therapeutics targeting antimitogen pathways.